112 related articles for article (PubMed ID: 12538019)
1. 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.
Huffman JW; Mabon R; Wu MJ; Lu J; Hart R; Hurst DP; Reggio PH; Wiley JL; Martin BR
Bioorg Med Chem; 2003 Feb; 11(4):539-49. PubMed ID: 12538019
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB(1) and CB(2) receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB(2) receptor agonists.
Huffman JW; Zengin G; Wu MJ; Lu J; Hynd G; Bushell K; Thompson AL; Bushell S; Tartal C; Hurst DP; Reggio PH; Selley DE; Cassidy MP; Wiley JL; Martin BR
Bioorg Med Chem; 2005 Jan; 13(1):89-112. PubMed ID: 15582455
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.
Huffman JW; Padgett LW
Curr Med Chem; 2005; 12(12):1395-411. PubMed ID: 15974991
[TBL] [Abstract][Full Text] [Related]
4. Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding.
Aung MM; Griffin G; Huffman JW; Wu M; Keel C; Yang B; Showalter VM; Abood ME; Martin BR
Drug Alcohol Depend; 2000 Aug; 60(2):133-40. PubMed ID: 10940540
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacology of 1-alkyl-3-(1-naphthoyl)indoles: steric and electronic effects of 4- and 8-halogenated naphthoyl substituents.
Wiley JL; Smith VJ; Chen J; Martin BR; Huffman JW
Bioorg Med Chem; 2012 Mar; 20(6):2067-81. PubMed ID: 22341572
[TBL] [Abstract][Full Text] [Related]
6. The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
Reggio PH; Basu-Dutt S; Barnett-Norris J; Castro MT; Hurst DP; Seltzman HH; Roche MJ; Gilliam AF; Thomas BF; Stevenson LA; Pertwee RG; Abood ME
J Med Chem; 1998 Dec; 41(26):5177-87. PubMed ID: 9857088
[TBL] [Abstract][Full Text] [Related]
7. Cannabimimetic indoles, pyrroles and indenes.
Huffman JW
Curr Med Chem; 1999 Aug; 6(8):705-20. PubMed ID: 10469887
[TBL] [Abstract][Full Text] [Related]
8. CB2 receptor ligands.
Huffman JW
Mini Rev Med Chem; 2005 Jul; 5(7):641-9. PubMed ID: 16026310
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the development of selective ligands for the cannabinoid CB(2) receptor.
Marriott KS; Huffman JW
Curr Top Med Chem; 2008; 8(3):187-204. PubMed ID: 18289088
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
Shim JY; Collantes ER; Welsh WJ; Subramaniam B; Howlett AC; Eissenstat MA; Ward SJ
J Med Chem; 1998 Nov; 41(23):4521-32. PubMed ID: 9804691
[TBL] [Abstract][Full Text] [Related]
11. The Spicy Story of Cannabimimetic Indoles.
Howlett AC; Thomas BF; Huffman JW
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684770
[TBL] [Abstract][Full Text] [Related]
12. Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.
Wiley JL; Marusich JA; Huffman JW
Life Sci; 2014 Feb; 97(1):55-63. PubMed ID: 24071522
[TBL] [Abstract][Full Text] [Related]
13. Aminoalkylindoles (AAIs): a new route to the cannabinoid receptor?
Ward SJ; Baizman E; Bell M; Childers S; D'Ambra T; Eissenstat M; Estep K; Haycock D; Howlett A; Luttinger D
NIDA Res Monogr; 1990; 105():425-6. PubMed ID: 1908557
[No Abstract] [Full Text] [Related]
14. Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB₁ and CB₂ receptors.
Uchiyama N; Kikura-Hanajiri R; Goda Y
Chem Pharm Bull (Tokyo); 2011; 59(9):1203-5. PubMed ID: 21881274
[TBL] [Abstract][Full Text] [Related]
15. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
16. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles.
Huffman JW; Szklennik PV; Almond A; Bushell K; Selley DE; He H; Cassidy MP; Wiley JL; Martin BR
Bioorg Med Chem Lett; 2005 Sep; 15(18):4110-3. PubMed ID: 16005223
[TBL] [Abstract][Full Text] [Related]
17. A 3D-QSAR study on the structural requirements for binding to CB(1) and CB(2) cannabinoid receptors.
Fichera M; Cruciani G; Bianchi A; Musumarra G
J Med Chem; 2000 Jun; 43(12):2300-9. PubMed ID: 10882356
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs).
Dutta AK; Ryan W; Thomas BF; Singer M; Compton DR; Martin BR; Razdan RK
Bioorg Med Chem; 1997 Aug; 5(8):1591-600. PubMed ID: 9313864
[TBL] [Abstract][Full Text] [Related]
19. The difference between the CB(1) and CB(2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2).
Song ZH; Slowey CA; Hurst DP; Reggio PH
Mol Pharmacol; 1999 Oct; 56(4):834-40. PubMed ID: 10496968
[TBL] [Abstract][Full Text] [Related]
20. Indol-3-yl-tetramethylcyclopropyl ketones: effects of indole ring substitution on CB2 cannabinoid receptor activity.
Frost JM; Dart MJ; Tietje KR; Garrison TR; Grayson GK; Daza AV; El-Kouhen OF; Miller LN; Li L; Yao BB; Hsieh GC; Pai M; Zhu CZ; Chandran P; Meyer MD
J Med Chem; 2008 Mar; 51(6):1904-12. PubMed ID: 18311894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]